175 related articles for article (PubMed ID: 35637955)
1. UBE2S as a novel ubiquitinated regulator of p16 and β-catenin to promote bone metastasis of prostate cancer.
Peng S; Chen X; Huang C; Yang C; Situ M; Zhou Q; Ling Y; Huang H; Huang M; Zhang Y; Cheng L; Zhang Q; Guo Z; Lai Y; Huang J
Int J Biol Sci; 2022; 18(8):3528-3543. PubMed ID: 35637955
[TBL] [Abstract][Full Text] [Related]
2. UBE2S interacting with TRIM21 mediates the K11-linked ubiquitination of LPP to promote the lymphatic metastasis of bladder cancer.
Xiao K; Peng S; Lu J; Zhou T; Hong X; Chen S; Liu G; Li H; Huang J; Chen X; Lin T
Cell Death Dis; 2023 Jul; 14(7):408. PubMed ID: 37422473
[TBL] [Abstract][Full Text] [Related]
3. Ube2s stabilizes β-Catenin through K11-linked polyubiquitination to promote mesendoderm specification and colorectal cancer development.
Li Z; Wang Y; Li Y; Yin W; Mo L; Qian X; Zhang Y; Wang G; Bu F; Zhang Z; Ren X; Zhu B; Niu C; Xiao W; Zhang W
Cell Death Dis; 2018 May; 9(5):456. PubMed ID: 29674637
[TBL] [Abstract][Full Text] [Related]
4. Ube2S regulates Wnt/β-catenin signaling and promotes the progression of non-small cell lung cancer.
Qin Y; Du J; Fan C
Int J Med Sci; 2020; 17(2):274-279. PubMed ID: 32038111
[TBL] [Abstract][Full Text] [Related]
5. UBE2S mediates tumor progression via SOX6/β-Catenin signaling in endometrial cancer.
Lin M; Lei T; Zheng J; Chen S; Du L; Xie H
Int J Biochem Cell Biol; 2019 Apr; 109():17-22. PubMed ID: 30690078
[TBL] [Abstract][Full Text] [Related]
6. Ube2s-stabilized β-catenin protects against myocardial ischemia/reperfusion injury by activating HIF-1α signaling.
Chen X; Wang C; Yang P; Shi L; Wang H
Aging (Albany NY); 2020 Apr; 12(7):5716-5732. PubMed ID: 32250966
[TBL] [Abstract][Full Text] [Related]
7. UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway.
Hu W; Li M; Chen Y; Gu X
J Ovarian Res; 2021 Sep; 14(1):121. PubMed ID: 34535173
[TBL] [Abstract][Full Text] [Related]
8. UBE2S drives elongation of K11-linked ubiquitin chains by the anaphase-promoting complex.
Wu T; Merbl Y; Huo Y; Gallop JL; Tzur A; Kirschner MW
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1355-60. PubMed ID: 20080579
[TBL] [Abstract][Full Text] [Related]
9. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling.
Li Q; Ye L; Zhang X; Wang M; Lin C; Huang S; Guo W; Lai Y; Du H; Li J; Song L; Peng X
Cancer Lett; 2017 Aug; 402():166-176. PubMed ID: 28602974
[TBL] [Abstract][Full Text] [Related]
10. UBE2S exerts oncogenic activities in urinary bladder cancer by ubiquitinating TSC1.
Tang H; Fang T; Ji M; Wang JP; Song LL; Zhang QY; Wu JS
Biochem Biophys Res Commun; 2021 Nov; 578():7-14. PubMed ID: 34520980
[TBL] [Abstract][Full Text] [Related]
11. UBE2S interacting with TRIM28 in the nucleus accelerates cell cycle by ubiquitination of p27 to promote hepatocellular carcinoma development.
Zhang RY; Liu ZK; Wei D; Yong YL; Lin P; Li H; Liu M; Zheng NS; Liu K; Hu CX; Yang XZ; Chen ZN; Bian H
Signal Transduct Target Ther; 2021 Feb; 6(1):64. PubMed ID: 33589597
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
Hong X; Yu JJ
Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
[TBL] [Abstract][Full Text] [Related]
13. UBE2S enhances the ubiquitination of p53 and exerts oncogenic activities in hepatocellular carcinoma.
Pan YH; Yang M; Liu LP; Wu DC; Li MY; Su SG
Biochem Biophys Res Commun; 2018 Sep; 503(2):895-902. PubMed ID: 29928880
[TBL] [Abstract][Full Text] [Related]
14. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Huang S; Wa Q; Pan J; Peng X; Ren D; Huang Y; Chen X; Tang Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):173. PubMed ID: 29202848
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.
Wang W; Yang X; Dai J; Lu Y; Zhang J; Keller ET
Oncogene; 2019 Jun; 38(23):4540-4559. PubMed ID: 30755731
[TBL] [Abstract][Full Text] [Related]
17. LRP5 knockdown: effect on prostate cancer invasion growth and skeletal metastasis in vitro and in vivo.
Rabbani SA; Arakelian A; Farookhi R
Cancer Med; 2013 Oct; 2(5):625-35. PubMed ID: 24403228
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
19. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition.
Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J
Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676
[TBL] [Abstract][Full Text] [Related]
20. SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation.
Kuang P; Tan M; Zhou W; Zhang Q; Sun Y
Sci Rep; 2016 Dec; 6():37441. PubMed ID: 27910872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
